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Abstract
Background:  Moderate alcohol consumption is protective against coronary artery disease.
Endothelial dysfunction contributes to atherosclerosis and the pathogenesis of cardiovascular
disease. The effects of alcohol consumption on endothelial function may be relevant to these
cardiovascular outcomes, but very few studies have examined the effect of alcohol consumption on
endothelial function assessed by flow-mediated dilation (FMD) of the brachial artery in humans.
Methods: In the population-based Northern Manhattan Study (NOMAS), we performed a cross-
sectional analysis of lifetime alcohol intake and brachial artery FMD during reactive hyperemia using
high-resolution B-mode ultrasound images among 884 stroke-free participants (mean age 66.8
years, women 56.6%, Hispanic 67.4%, black 17.4%, and white 15.2%).
Results: The mean brachial FMD was 5.7% and the median was 5.5%. Compared to non-drinkers,
those who drank >1 drink/month to 2 drinks/day were more likely to have FMD above the median
FMD (5.5%) (unadjusted OR 1.7, 95% CI 1.2–2.4, p = 0.005). In multivariate analysis, the
relationship between moderate alcohol consumption and FMD remained significant after adjusting
for multiple traditional cardiovascular risk factors, including sex, race-ethnicity, body mass index,
diabetes mellitus, coronary artery disease, Framingham risk score, medication use (adjusted OR
1.8, 95%CI 1.1–3.0, p = 0.03). No beneficial effect on FMD was seen for those who drank more
than 2 drinks/day.
Conclusion: In conclusion, consumption of up to 2 alcoholic beverages per day was independently
associated with better FMD compared to no alcohol consumption in this multiethnic population.
This effect on FMD may represent an important mechanism in explaining the protective effect of
alcohol intake on cardiovascular disease.
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Background
Epidemiologic evidence suggests that moderate alcohol
consumption is associated with a reduced risk of develop-
ing coronary artery disease (CAD) [1-4]. The relationship
between alcohol intake and the risk of developing CAD is
a J- or U-shaped dose-response: the risk is higher in indi-
viduals not consuming any alcohol, low when alcohol
consumption is low or moderate, and tends to go up again
when alcohol consumption is high[5]. The mechanism
underlying the cardioprotective effects of moderate alco-
hol consumption may involve prevention of atherogene-
sis through beneficial alcohol-induced changes in serum
lipids, blood clotting proteins and insulin resistance[5],
although not all of these changes are well understood.
Endothelial dysfunction contributes to atherosclerosis
and to the pathogenesis of cardiovascular disease[6,7],
but few human studies have examined the effects of alco-
hol on endothelial function. Flow-mediated dilation
(FMD) of the brachial artery assessed by high-resolution
ultrasonography is widely used for the non-invasive
assessment of endothelial function[8]. FMD is dimin-
ished in patients with vascular risk factors such as aging,
smoking, hypertension, dyslipidemia and diabetes melli-
tus, and FMD improves with risk-reduction therapy[6,7].
The objective of this study was to investigate the associa-
tion between alcohol consumption and endothelial func-
tion in order to explore one potential mechanism of the
protective effect of alcohol intake on cardiovascular dis-
ease.
Methods
Study population
Subjects were drawn from the Northern Manhattan Study
(NOMAS), an ongoing population-based prospective
cohort study designed to investigate cardiovascular and
stroke risk factors in a multi-ethnic sample (white, black,
and Hispanic) of stroke-free individuals from northern
Manhattan. Recruitment modalities have been previously
published[9,10]. Briefly, between January 1998 and April
2001, high quality ultrasound images and measurements
of FMD were performed in 884 participants from NOMAS
participants. Written informed consent was obtained
from all subjects, and the study was approved by the Insti-
tutional Review Board of Columbia University Medical
Center.
Baseline clinical evaluation
Baseline evaluation was performed at enrollment as previ-
ously reported[9,10]. Briefly, race-ethnicity was catego-
rized into four groups: Hispanic, non-Hispanic black,
non-Hispanic white, and other. Blood was taken from
fasting subjects, and standard enzymatic methods were
used for the sample analyses. Cardiovascular risk factors
were collected by direct interview and were defined as in
the prior publication[10]. Hypertension was defined as a
systolic blood pressure (SBP) recording >140 mmHg or
diastolic blood pressure (DBP) recording >90 mmHg dur-
ing one sitting based on the mean of two readings of the
blood pressure measurements, a patient's self-report of a
history of hypertension, or antihypertensive medication
use. Diabetes mellitus was defined by one or more of the
following: a patient's self-report of such a history, insulin
use, oral hypoglycemic use, or fasting glucose>126 mg/dl.
Hypercholesterolemia was defined by a patient's self-
report of hypercholesterolemia, use of lipid lowering ther-
apy, or a fasting total cholesterol level >240 mg/dL. Body
mass index was calculated as weight (kg) divided by
height (m) squared. Coronary artery disease (CAD) was
defined by self-report of history of heart attack, bypass
surgery or angioplasty. Framingham risk score was com-
puted from baseline risk factor data. This score takes into
account data on age (per each 5 years), total cholesterol,
high density lipoprotein cholesterol, systolic blood pres-
sure, and cigarette smoking and estimate the 10-year risk
for coronary artery disease (CAD) in each gender[11].
Flow-mediated dilation assessment
Arterial endothelial function defined as the brachial artery
response to hyperemia was non-invasively assessed using
high resolution B-mode ultrasonography as previously
described[10]. Participants fasted for 12 hours, and also
avoided exercise for at least 4–6 hours prior to the FMD
examinations. The brachial artery diameter was measured
6 cm above the antecubital crease using a 15 MHz liner
array transducer (Phillips 5500, Andover, MA). FMD was
measured as the dilator response to reactive hyperemia
induced by 5 minute blood pressure cuff occlusion of the
upper arm. The cuff was inflated to at least 50 mmHg
above SBP to occlude arterial flow. End-diastolic images
were acquired and digitized by a frame grabber (model
LG3, Scion Corporation) at baseline and 1 min after cuff
deflation. A blinded reader analyzed brachial artery diam-
eters off-line using analysis software. Three consecutive
cardiac cycles were analyzed for both baseline and hyper-
emia studies of each subject, and the measurements aver-
aged. FMD was expressed as percent change from rest:
Intraobserver variability for FMD measurements was
1.3%.
Alcohol consumption assessment
The alcohol consumption assessment was described pre-
viously[12,13]. Research assistants used structured in-per-
son interviews adapted from the National Cancer Institute
Food Frequency questionnaire[14] and the Willett Food
Frequency questionnaire[15]. Inquiries were made about
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consumption of wine, beer and liquor on average during
each participant's lifetime. The defined response regard-
ing frequency allowed 9 possibilities ranging from never
to more than 6 drinks per day. The responses for each bev-
erage type were summed to obtain a total quantity, and an
average daily quantity was calculated. A standard drink of
wine was considered to contain 4 ounces, beer 12 ounces,
and liquor 1.5 ounces of ethanol. The reliability and valid-
ity of alcohol assessment has been shown previously to be
good in our population[12].
Statistical analysis
The categorization of alcohol consumption was the same
as in the previous publications[13,1] less than 1 drink/
month; [2] 1 drink/month to 2 drinks/day; and [3] more
than 2 drinks/day. All statistical analyses were performed
using SAS 9.1 (SAS Institute, Cary, NC). The association
between FMD and alcohol consumption was analyzed by
univariate and multivariable logistic regression analyses.
The dependent variable, FMD, was dichotomized using
the median level of the FMD distribution.
Results
Table 1 shows the characteristics of the 884 participants.
The mean age was 66.8 years, 43.4% were men. The mean
brachial FMD was 5.7% and the median was 5.5%. Table
2 shows that moderate drinkers (1 drink/month to 2
drinks/day) were more likely to have FMD above the
median of FMD (unadjusted OR 1.7, 95% CI 1.2–2.4, p =
0.005) compared to non-drinkers. In multivariate analy-
sis, the relationship between moderate lifetime alcohol
consumption and FMD remained significant after adjust-
ing for sex, race-ethnicity, body mass index, diabetes mel-
litus, CAD, Framingham risk score and medication use
(cholesterol lowering agents, aspirin, insulin, oral
hypoglycemic agents, ACE inhibitors, beta-blockers, cal-
cium channel blockers and diuretics) (adjusted OR 1.8,
95%CI 1.1–3.0 p = 0.03). No beneficial effect on FMD was
seen for those who drank more than 2 drinks/day.
Among the 884 study participants, 74 (8.4%) subjects had
CAD. Among those 74 subjects, 18 (24.3%) had less than
1 drink/month, 44 (59.5%) had 1 drink/month to 2
drinks/day, and 12 (16.2%) had more than 2 drinks/day.
Among the 810 subjects who did not have CAD, 129
(15.9%) had less than 1 drink/month, 574 (70.9%) had 1
drink/month to 2 drinks/day, and 107 (13.2%) had more
than 2 drinks/day. No association was found between
CAD and alcohol consumption (Chi-square test = 4.6
with 2 degrees of freedom, p = N.S).
Discussion
Our data provide evidence that moderate alcohol con-
sumption is associated with better FMD, independent of
traditional vascular risk factors. The categorization of
moderate alcohol consumption was the same as in a pre-
vious publication[13]. To the best of our knowledge, our
study is the first to obtain data from a large multi-ethnic,
population-based cohort showing the beneficial effect of
moderate alcohol drinking on FMD. Distinctive features
of our cohort are the elderly, mostly Hispanic population,
a high proportion of women, high prevalence of hyper-
tension, high body mass index, and lower than expected
proportion of smokers. Other studies in selected popula-
tions have shown similar associations. For example, FMD
was higher in moderate drinkers compared to non-drink-
ers among Japanese men with CAD[16].
Brachial artery FMD reflects NO-dependent endothelial
function[17]. The synthesis of endothelial NO from L-
arginine is regulated by endogenous nitric oxide synthase
(eNOS)[18]. The endothelium regulates vascular homeos-
tasis and is essential for vasodilation in response to
increases in blood flow-associated shear stress[19].
Endothelial dysfunction is characterized by an impaired
endothelium-dependent vasodilation response and
decreased production and local bioavailability of NO[6].
Table 1: Characteristics of study participants
Characteristic Mean (SD) or n (%)
Total number 884
Age (years) 66.8 (8.8)
Men 384 (43.4)
Race-ethnicity
Hispanics 596 (67.4)
Non-Hispanic Black 154 (17.4)
Non-Hispanic White 134 (15.2)
Hypertension 603 (68.2)
Diabetes Mellitus 202 (22.9)
Hyperlipidemia 435(49.3%)
Current smoking 140 (16.0)
History of smoking 478 (54.1)
Body mass index (kg/m2) 27.9 (5.1)
Systolic BP (mmHg) 143 (19)
Diastolic BP (mmHg) 84 (10)
Total cholesterol (mg/dl) 202.1 (39.7)
HDL cholesterol (mg/dl) 45.6 (14.0)
LDL cholesterol (mg/dl) 130.2 (35.8)
Blood Glucose (mg/dl) 105.0 (48.8)
CAD 74(8.4%)
Framingham risk score 16.9+/-3.7
FMD(%), mean(SD) 5.7 (3.8)
FMD(%), median 5.5
Medications
Aspirin 244(27.7%)
Cholesterol lowering agents 162(18.4%)
Insulin 37(4.2%)
Oral hypoglycemic 129(14.7%)
Medication for blood pressure 393(69.8%)
ACE inhibitor 45(5.1%)
Beta-Blocker 41(4.7%)
Calcium channel blocker 40(4.6%)
Diuretics 124(14.1%)BMC Cardiovascular Disorders 2009, 9:8 http://www.biomedcentral.com/1471-2261/9/8
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Impaired FMD is also associated with atherosclerosis and
predisposes to CAD.
Our findings indicate the possibility that a chronic effect
of moderate alcohol consumption is beneficial to
endothelial function. While the acute and chronic
responses of vascular endothelium to alcohol may be dif-
ferent, neither is fully understood. In acute interventional
studies, most of which assessed the effect of wine, some
reported that FMD of the brachial artery was improved
several hours after ingestion of wine[20], while others
observed that the polyphenolic components, rather than
alcohol itself, improved FMD among healthy volunteers
and patients with CAD[21,22]. One study reported that
alcohol produced significant vasodilatation of a brachial
artery at resting condition and it led to a significant
increase in the artery diameter at reactive hyperemia; how-
ever, the percentage of FMD did not change in healthy
subjects[23].
Previous in vitro experimental studies suggested that low
concentrations of alcohol promote endothelial cell sur-
vival[24] and increase eNOS expression and NO produc-
tion in both basal and flow stimulated activity [25-27].
These findings might provide a mechanism to explain the
possible beneficial effect of moderate alcohol consump-
tion on endothelial function.
Several putative biological mechanisms have been pro-
posed to explain the cardioprotective effect of moderate
alcohol consumption. Moderate alcohol consumption
increases HDL, reduces platelet aggregation and fibrino-
gen levels, increases fibrinolysis, and also improves blood
insulin sensitivity and reduces insulin resistance[5].
Although we were not able to adjust for all of these factors,
our data suggest the possibility that moderate alcohol
consumption directly influences endothelial function.
Further research would be necessary to assess the relation-
ship between alcohol and endothelial function both in
acute and long term human research and experimental
research.
This study has several limitations. First, this is a cross-sec-
tional study, and therefore a causal relationship cannot be
established. Second, the use of self-reported information
on alcohol intake may have introduced misclassification
of exposure, most likely an underestimation of alcohol
consumption. Third, we are not able to investigate any dif-
ferential effect across types of alcoholic beverages. Fourth,
due to unequal distribution of reported average alcohol
consumption categories, there exists a possibility that this
imbalance may have affected the results. Finally, we did
not examine endothelial-independent vasodilation with
nitroglycerin in our cohort.
Conclusion
In conclusion, average consumption of up to 2 alcoholic
beverages per day was independently associated with bet-
ter FMD compared to consumption of less than 1 drink
per month in this multiethnic population. This effect on
FMD may represent an important mechanism in explain-
ing the protective effect of alcohol consumption on cardi-
ovascular disease.
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